135 related articles for article (PubMed ID: 29637898)
1. A 6-month follow-up of disability, quality of life, and depressive and anxiety symptoms in pediatric migraine with magnesium prophylaxis.
Kovacevic G; Stevanovic D; Bogicevic D; Nikolic D; Ostojic S; Tadic BV; Nikolic B; Bosiocic I; Ivancevic N; Jovanovic K; Samardzic J; Jancic J
Magnes Res; 2017 Nov; 30(4):133-141. PubMed ID: 29637898
[TBL] [Abstract][Full Text] [Related]
2. The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up.
Hung CI; Liu CY; Yang CH; Wang SJ
PLoS One; 2015; 10(5):e0128087. PubMed ID: 26000962
[TBL] [Abstract][Full Text] [Related]
3. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Psychopathology and Quality of Life in Children and Adolescents With Migraine.
Öztop DB; Taşdelen Bİ; PoyrazoğLu HG; Ozsoy S; Yilmaz R; Şahın N; Per H; Bozkurt S
J Child Neurol; 2016 Jun; 31(7):837-42. PubMed ID: 26759448
[TBL] [Abstract][Full Text] [Related]
5. Anxiety and depressive symptoms and migraine-related outcomes in children and adolescents.
Rizvi BA; Kuziek J; Cho LY; Ronksley PE; Noel MN; Orr SL
Headache; 2024 Apr; 64(4):342-351. PubMed ID: 38581204
[TBL] [Abstract][Full Text] [Related]
6. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
7. The relationships between migraine, depression, anxiety, stress, and sleep disturbances.
Yalinay Dikmen P; Yavuz BG; Aydinlar EI
Acta Neurol Belg; 2015 Jun; 115(2):117-22. PubMed ID: 24889393
[TBL] [Abstract][Full Text] [Related]
8. Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial.
Mitsikostas DD; Vikelis M; Kodounis A; Zaglis D; Xifaras M; Doitsini S; Georgiadis G; Thomas A; Charmoussi S
Cephalalgia; 2010 Jun; 30(6):690-5. PubMed ID: 20511208
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine.
Paschoal JK; Lin J; Pinho RS; Andreoni S; Minett TS; Vitalle MS; Fisberg M; Peres MF; Vilanova LC; Masruha MR
Pediatr Int; 2013 Dec; 55(6):741-7. PubMed ID: 23829487
[TBL] [Abstract][Full Text] [Related]
10. Migraine features in migraineurs with and without anxiety-depression symptoms: a hospital-based study.
Baldacci F; Lucchesi C; Cafalli M; Poletti M; Ulivi M; Vedovello M; Giuntini M; Mazzucchi S; Del Prete E; Vergallo A; Nuti A; Gori S
Clin Neurol Neurosurg; 2015 May; 132():74-8. PubMed ID: 25804622
[TBL] [Abstract][Full Text] [Related]
11. Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder.
Hung CI; Liu CY; Yang CH; Wang SJ
J Headache Pain; 2018 Jul; 19(1):56. PubMed ID: 30019214
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.
Peikert A; Wilimzig C; Köhne-Volland R
Cephalalgia; 1996 Jun; 16(4):257-63. PubMed ID: 8792038
[TBL] [Abstract][Full Text] [Related]
13. The effect of maternal migraine headache on their children's quality of life.
Güngen BD; Aras YG; Gül SS; Acar T; Ayaz AB; Alagöz AN; Acar BA
Acta Neurol Belg; 2017 Sep; 117(3):687-694. PubMed ID: 28536973
[TBL] [Abstract][Full Text] [Related]
14. Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.
Orr SL; Venkateswaran S
Cephalalgia; 2014 Jul; 34(8):568-83. PubMed ID: 24443395
[TBL] [Abstract][Full Text] [Related]
15. Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptoms.
Holroyd KA; Drew JB; Cottrell CK; Romanek KM; Heh V
Cephalalgia; 2007 Oct; 27(10):1156-65. PubMed ID: 17784854
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and its correlates in adolescent multiple sclerosis patients.
Ostojic S; Stevanovic D; Jancic J
Mult Scler Relat Disord; 2016 Nov; 10():57-62. PubMed ID: 27919499
[TBL] [Abstract][Full Text] [Related]
17. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
18. Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.
Moreira JM; Bouissou Morais Soares CM; Teixeira AL; Simões E Silva AC; Kummer AM
Pediatr Nephrol; 2015 Dec; 30(12):2153-62. PubMed ID: 26210984
[TBL] [Abstract][Full Text] [Related]
19. Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients.
Lucchesi C; Baldacci F; Cafalli M; Dini E; Giampietri L; Siciliano G; Gori S
Neurol Sci; 2016 Jun; 37(6):987-9. PubMed ID: 26879311
[TBL] [Abstract][Full Text] [Related]
20. Anxiety, stress and coping behaviours in primary care migraine patients: results of the SMILE study.
Radat F; Mekies C; Géraud G; Valade D; Vivès E; Lucas C; Joubert JM; Lantéri-Minet M
Cephalalgia; 2008 Nov; 28(11):1115-25. PubMed ID: 18644041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
